Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Krka dd Novo Mesto
ISIN SI0031102120
|WKN 903246
Market cap (in EUR)
8,182 m
Country
Slovenia
Sector
Healthcare
Dividend yield
3.65%
Overview
Description
Krka dd Novo Mesto is a generic pharmaceutical company, which engages in the development, production, marketing, and sale of human and animal health products. It operates through the following geographical segments: European Union, South-Eastern Europe, Eastern Europe, and Other. The European Union segment includes all countries of the European Union. The South-Eastern Europe segment consists of Serbia, Bosnia and Herzegovina, Macedonia, Montenegro, Kosovo, and Albania. The Eastern Europe segment comprises of the Russian Federation and other former Soviet Union countries, excluding the Baltic countries. The company was founded by Boris Andrijanic in 1954 and is headquartered in Novo Mesto, Slovenia.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Slovenia
Financials
Key metrics
| Market capitalisation, EUR | 8,182 m |
| EPS, EUR | 14.67 |
| P/B ratio | 3.1 |
| P/E ratio | 17.0 |
| Dividend yield | 3.65% |
Income statement (2025)
| Revenue, EUR | 2,041 m |
| Net income, EUR | 403 m |
| Profit margin | 19.76% |
What ETF is Krka dd Novo Mesto in?
There is 1 ETF which contains Krka dd Novo Mesto.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Expat Slovenia SBI TOP UCITS ETF | 28.36% | Equity Slovenia | 1 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.